ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors. - Shin, Seol Hwa; Ju, Eun Jin; Park, Jin; Ko, Eun Jung; Kwon, Mi Ri; Lee, Hye Won; Son, Ga Won; Park, Yun-Yong; Kim, Yeon Joo; Song, Si Yeol; Lee, Sangkwang; Seo, Beom Seok; et al. (Cancer Cell International, 2023)